{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:49:32Z","timestamp":1791823772156,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disorder characterized by impaired surfactant clearance due to alveolar macrophage dysfunction. Leuprorelin acetate, a gonadotropin-releasing hormone agonist, is widely used in the treatment of ovarian endometriosis; however, pulmonary findings associated with this therapy have not been well characterized. We report a case of PAP diagnosed during leuprorelin acetate therapy for ovarian endometrioma and describe its temporal relationship with treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 29-year-old woman underwent laparoscopic surgery for an ovarian endometrioma in August 2025 and initiated leuprorelin acetate therapy three days postoperatively. A routine chest computed tomography (CT) performed one month later revealed scattered bilateral ground-glass opacities (GGOs), which persisted on repeat CT in November 2025. Although the patient remained asymptomatic, video-assisted thoracoscopic surgery (VATS) lung biopsy was performed to obtain a histopathological diagnosis and confirmed PAP. Serum anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody testing was negative (3.2\u00a0\u00b5g\/mL; reference range, \u2264\u20095\u00a0\u00b5g\/mL), not supporting autoimmune PAP. During treatment, the patient developed transient Common Terminology Criteria for Adverse Events (CTCAE) grade 2 leukopenia (white blood cell nadir, 2.94\u2009\u00d7\u200910\u2079\/L), which resolved spontaneously after completion of leuprorelin acetate therapy without intervention. Hematological evaluation did not suggest an underlying clonal disorder, including myelodysplastic syndrome. Because baseline chest imaging was unavailable, pre-existing subclinical PAP could not be excluded. Follow-up CT performed three months after completion of therapy showed regression of GGOs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case shows a temporal relationship between leuprorelin acetate therapy and non-autoimmune PAP. However, causality cannot be inferred in the absence of baseline imaging. Only a temporal association can be observed. This observation is hypothesis-generating and highlights a potential rare pulmonary finding observed in the context of gonadotropin-releasing hormone agonist therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-026-04507-5","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:26:48Z","timestamp":1784262408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary alveolar proteinosis diagnosed during leuprorelin acetate therapy for ovarian endometrioma: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Xin","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"23","key":"4507_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJM195806052582301","volume":"258","author":"SH Rosen","year":"1958","unstructured":"Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med. 1958;258(23):1123\u201342.","journal-title":"N Engl J Med"},{"issue":"7","key":"4507_CR2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S2213-2600(18)30043-2","volume":"6","author":"A Kumar","year":"2018","unstructured":"Kumar A, Abdelmalak B, Inoue Y, Culver DA. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach. Lancet Respiratory Med. 2018;6(7):554\u201365.","journal-title":"Lancet Respiratory Med"},{"issue":"3 Pt 1","key":"4507_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/ajrccm.149.3.8118651","volume":"149","author":"C Cordonnier","year":"1994","unstructured":"Cordonnier C, Fleury-Feith J, Escudier E, Atassi K, Bernaudin JF. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med. 1994;149(3 Pt 1):788\u201394.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"4507_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1183\/09031936.04.00102704","volume":"23","author":"M Beccaria","year":"2004","unstructured":"Beccaria M, Luisetti M, Rodi G, Corsico A, Zoia MC, Colato S, Pochetti P, Braschi A, Pozzi E, Cerveri I. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J. 2004;23(4):526\u201331.","journal-title":"Eur Respir J"},{"issue":"10","key":"4507_CR5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1164\/rccm.200406-716OC","volume":"171","author":"R Tazawa","year":"2005","unstructured":"Tazawa R, Hamano E, Arai T, Ohta H, Ishimoto O, Uchida K, Watanabe M, Saito J, Takeshita M, Hirabayashi Y, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2005;171(10):1142\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4507_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12884-024-06430-1","volume":"24","author":"X Qing","year":"2024","unstructured":"Qing X, He L, Ma Y, Zhang Y, Zheng W. Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery. BMC Pregnancy Childbirth. 2024;24(1):237.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"4507_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1677\/joe.0.1760293","volume":"176","author":"F Tanriverdi","year":"2003","unstructured":"Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol. 2003;176(3):293\u2013304.","journal-title":"J Endocrinol"},{"key":"4507_CR8","doi-asserted-by":"crossref","unstructured":"Zakharova L, Sharova V, Izvolskaia M. Mechanisms of Reciprocal Regulation of Gonadotropin-Releasing Hormone (GnRH)-Producing and Immune Systems: The Role of GnRH, Cytokines and Their Receptors in Early Ontogenesis in Normal and Pathological Conditions. Int J Mol Sci. 2020; 22(1).","DOI":"10.3390\/ijms22010114"},{"issue":"2","key":"4507_CR9","first-page":"743","volume":"84","author":"HF Chen","year":"1999","unstructured":"Chen HF, Jeung EB, Stephenson M, Leung PC. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J Clin Endocrinol Metab. 1999;84(2):743\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"4507_CR10","doi-asserted-by":"publisher","first-page":"1023104","DOI":"10.3389\/fimmu.2022.1023104","volume":"13","author":"F Pan","year":"2022","unstructured":"Pan F, Du H, Tian W, Xie H, Zhang B, Fu W, Li Y, Ling Y, Zhang Y, Fang F, et al. Effect of GnRH immunocastration on immune function in male rats. Front Immunol. 2022;13:1023104.","journal-title":"Front Immunol"},{"key":"4507_CR11","doi-asserted-by":"crossref","unstructured":"Ho HN, Chen HF, Chen SU, Chao KH, Yang YS, Huang SC, Lee TY, Gill TJ. 3rd: Gonadotropin releasing hormone (GnRH) agonist induces down-regulation of the CD3\u2009+\u2009CD25+ lymphocyte subpopulation in peripheral blood. American journal of reproductive immunology (New York, NY: 1989) 1995; 33(3):243\u2013252.","DOI":"10.1111\/j.1600-0897.1995.tb00891.x"},{"issue":"1","key":"4507_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12916-025-04162-3","volume":"23","author":"AL Zippl","year":"2025","unstructured":"Zippl AL, Kyvelidou C, Frank M, Gapp E, Reiser E, Braun AS, Feil K, Schuchter S, Rockenschaub P, Toth B, et al. The impact of GnRH agonists on endometrial immune cells in patients with adenomyosis: a prospective cohort study. BMC Med. 2025;23(1):338.","journal-title":"BMC Med"},{"issue":"1","key":"4507_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000438927","volume":"23","author":"I Guzm\u00e1n-Soto","year":"2016","unstructured":"Guzm\u00e1n-Soto I, Salinas E, Quintanar JL. Leuprolide Acetate Inhibits Spinal Cord Inflammatory Response in Experimental Autoimmune Encephalomyelitis by Suppressing NF-\u03baB Activation. Neuroimmunomodulation. 2016;23(1):33\u201340.","journal-title":"Neuroimmunomodulation"},{"key":"4507_CR14","doi-asserted-by":"crossref","unstructured":"Chen LH, Lo WC, Huang HY, Wu HM. A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment. Int J Mol Sci. 2023; 24(8).","DOI":"10.3390\/ijms24087503"},{"key":"4507_CR15","doi-asserted-by":"crossref","unstructured":"Chakraborty B, Byemerwa J, Shepherd J, Haines CN, Baldi R, Gong W, Liu W, Mukherjee D, Artham S, Lim F et al. Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma. J Clin Investig. 2021; 131(23).","DOI":"10.1172\/JCI151347"},{"key":"4507_CR16","doi-asserted-by":"publisher","first-page":"104971","DOI":"10.1016\/j.yexmp.2025.104971","volume":"143","author":"A Belboul","year":"2025","unstructured":"Belboul A, Ashworth J, Fadel A, McLoughlin J, Mahmoud A, El Mohtadi M. Estrogen induces the alternative activation of macrophages through binding to estrogen receptor-alpha. Exp Mol Pathol. 2025;143:104971.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"4507_CR17","doi-asserted-by":"publisher","first-page":"E50","DOI":"10.1210\/jc.2014-2751","volume":"100","author":"A Toniolo","year":"2015","unstructured":"Toniolo A, Fadini GP, Tedesco S, Cappellari R, Vegeto E, Maggi A, Avogaro A, Bolego C, Cignarella A. Alternative activation of human macrophages is rescued by estrogen treatment in vitro and impaired by menopausal status. J Clin Endocrinol Metab. 2015;100(1):E50\u201358.","journal-title":"J Clin Endocrinol Metab"},{"key":"4507_CR18","doi-asserted-by":"publisher","first-page":"15224","DOI":"10.1038\/srep15224","volume":"5","author":"A Villa","year":"2015","unstructured":"Villa A, Rizzi N, Vegeto E, Ciana P, Maggi A. Estrogen accelerates the resolution of inflammation in macrophagic cells. Sci Rep. 2015;5:15224.","journal-title":"Sci Rep"},{"issue":"12","key":"4507_CR19","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/jnci\/djab111","volume":"113","author":"W Cui","year":"2021","unstructured":"Cui W, Francis PA, Loi S, Hickey M, Stern C, Na L, Partridge AH, Loibl S, Anderson RA, Hutt KJ, et al. Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation. J Natl Cancer Inst. 2021;113(12):1770\u20138.","journal-title":"J Natl Cancer Inst"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04507-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04507-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04507-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:06:06Z","timestamp":1791821166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04507-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4507"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04507-5","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of this case report and any accompanying images was obtained from the patient. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"460"}}